Kymera Therapeutics, Inc. · NASDAQ:KYMR

Chadwick Jeremy G sold 22,240 Kymera Therapeutics, Inc. shares (Form 4)

Traded Mar 31 to Apr 1, 2026 · Filed Apr 1, 2026

From Mar 31 to Apr 1, 2026, Chadwick Jeremy G (Chief Operating Officer) sold 22,240 Kymera Therapeutics, Inc. shares at an average US$85.43 for US$1.9M under a trading plan, leaving 61,202 shares. Filed Apr 1, 2026 (Form 4).

Sold
22,240 shares
Price
US$85.43 average (US$85.38 to US$86.05)
Value
US$1.9M
Holding after
61,202 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Operating Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Mar 31, 2026Common StockOption exercise7,600US$29.6468,802Direct
Mar 31, 2026Common StockSale7,600US$85.3861,202Direct
Apr 1, 2026Common StockOption exercise14,640US$29.6475,842Direct
Apr 1, 2026Common StockSale13,540US$85.4162,302Direct
Apr 1, 2026Common StockSale1,100US$86.0561,202Direct

Source

View original at SEC

Related